Skip to content

Requirement sevoflurane (an anesthetic agent) for two airway devices placement

Optimum Concentration of Sevoflurane for the Insertion I-gel and CLMA in unpremedicated children

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/04/004517
Enrollment
40
Registered
2014-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- pediatric patients who are scheduled to undergo elective cataract surgeries

Interventions

Intervention1: I-Gel Group: The first patient enrolled in the study was exposed to an end-tidal sevoflurane concentration of 2.4%. In subsequent patients, the end tidal concentration was increased or

Sponsors

Post Graduate Institute of Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: paediatric patients of ASA physical status I /II of either sex, in the age group of 1.5 years - 8 years, weighing 10 to 20 kg who are scheduled to undergo elective cataract surgeries

Exclusion criteria

Exclusion criteria: Children with Upper respiratory tract infection (cough, fever, rhinorrhea) at the day of surgery., Respiratory tract pathology ( oropharynx, larynx ), Anticipated difficult airway, Children at increased risk of aspiration - Gastro esophageal reflux disease, non fasting status , Hiatus hernia, Lung diseases, Cardiorespiratory or cerebrovascular disease

Design outcomes

Primary

MeasureTime frame
EC50 of Sevoflurane for successful LMA or I gel insertionTimepoint: At the time of LMA or I gel insertion

Secondary

MeasureTime frame
success rate of LMA or I gel placement, attempts to successful placements, incidence of coughing, clenching of teeth, complicationsTimepoint: At or one minute after LMA

Countries

India

Contacts

Public ContactDr Babita Ghai

Post Graduate Institute of Medical Education and Research

ghaibabita@hotmail.com09914209533

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026